Literature DB >> 6661730

Effect of cholinergic and anticholinergic drugs on short-term memory in Alzheimer's dementia: a neuropsychological and computerized electroencephalographic study.

A Agnoli, N Martucci, V Manna, L Conti, M Fioravanti.   

Abstract

A correlation was found among the degree of memory loss, intellectual impairment, the quantity of senile plaques, and a decrease in choline acetyltransferase and acetylcholinesterase activity in patients affected by senile dementia of the Alzheimer type. In this study, patients were subjected to a series of computerized electroencephalographic (EEG) recordings and neuropsychological evaluations after acute administration of the following drugs: placebo; the cholinergic drugs physostigmine, pyridostigmine bromide, and edrophonium chloride; and the anticholinergic drugs scopolamine and orphenadrine. The results obtained show that the acute administration of some cholinergic drugs improved memory and attention performances, whereas the anticholinergic drugs induced opposite effects. The cholinergic drugs exhibited a tendency to shift the EEG spectrum analysis into more normal patterns compatible with the patient's age. This study supports the view that the cholinergic system plays an important role in memory and attention disturbances found in senile dementia of the Alzheimer type.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6661730     DOI: 10.1097/00002826-198312000-00005

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  13 in total

1.  Study of the P300 and cerebral maps in subjects with multi-infarct dementia treated with cytidine.

Authors:  V Gallai; G Mazzotta; C Firenze; S Montesi; F Del Gatto
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Cognitive effects of scopolamine in dementia.

Authors:  J M Rabey; M Y Neufeld; T A Treves; P Sifris; A D Korczyn
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 3.  Physostigmine for Alzheimer's disease.

Authors:  F Coelho; J Birks
Journal:  Cochrane Database Syst Rev       Date:  2001

Review 4.  Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology.

Authors:  Harald Hampel; Nicola Toschi; Claudio Babiloni; Filippo Baldacci; Keith L Black; Arun L W Bokde; René S Bun; Francesco Cacciola; Enrica Cavedo; Patrizia A Chiesa; Olivier Colliot; Cristina-Maria Coman; Bruno Dubois; Andrea Duggento; Stanley Durrleman; Maria-Teresa Ferretti; Nathalie George; Remy Genthon; Marie-Odile Habert; Karl Herholz; Yosef Koronyo; Maya Koronyo-Hamaoui; Foudil Lamari; Todd Langevin; Stéphane Lehéricy; Jean Lorenceau; Christian Neri; Robert Nisticò; Francis Nyasse-Messene; Craig Ritchie; Simone Rossi; Emiliano Santarnecchi; Olaf Sporns; Steven R Verdooner; Andrea Vergallo; Nicolas Villain; Erfan Younesi; Francesco Garaci; Simone Lista
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 5.  Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer's disease.

Authors:  Krista L Lanctôt; Nathan Herrmann; Maysoon M LouLou
Journal:  J Psychiatry Neurosci       Date:  2003-01       Impact factor: 6.186

Review 6.  Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia.

Authors:  Martin Taylor-Rowan; Olga Kraia; Christina Kolliopoulou; Anna H Noel-Storr; Ahmed A Alharthi; Amanda J Cross; Carrie Stewart; Phyo K Myint; Jenny McCleery; Terry J Quinn
Journal:  Cochrane Database Syst Rev       Date:  2022-08-22

Review 7.  New treatments for dementia. Myth, magic, and science.

Authors:  R Ganesan; T Standish; D W Molloy; P Darzins; J B Orange
Journal:  Can Fam Physician       Date:  1994-06       Impact factor: 3.275

Review 8.  Pharmaceutical treatment for cognitive deficits in Alzheimer's disease and other neurodegenerative conditions: exploring new territory using traditional tools and established maps.

Authors:  Raymond T Bartus; Reginald L Dean
Journal:  Psychopharmacology (Berl)       Date:  2008-11-15       Impact factor: 4.530

9.  Urinary Urgency Medications May Compromise Discrete rather than Global Cognitive Skills.

Authors:  Marilee Monnot; Elliott Ross
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2012-06-20

10.  Functional and structural brain network correlates of visual hallucinations in Lewy body dementia.

Authors:  Ramtin Mehraram; Luis R Peraza; Nicholas R E Murphy; Ruth A Cromarty; Sara Graziadio; John T O'Brien; Alison Killen; Sean J Colloby; Michael Firbank; Li Su; Daniel Collerton; John Paul Taylor; Marcus Kaiser
Journal:  Brain       Date:  2022-06-30       Impact factor: 15.255

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.